Patients News | pharmaphorum

News

NICE backs Keytruda for incurable cervical cancer via CDF

Hundreds of NHS patients with an incurable form of cervical cancer will be able to get treatment using a combination regimen based on Merck & Co/MSD’s cancer immunothe

News

23andMe, Novartis team up to put Lp(a) on patients’ radar

Lipoprotein(a) is well established as a risk factor for cardiovascular disease, but patients rarely get tested for it.

News

Patients rely on Google more than information leaflets

It is time to look at new, digital ways to deliver patient information, suggests UK survey.

News

PTC’s gene therapy for rare disease cleared for NHS use

Upstaza has shown impressive clinical results in children with fatal disorder AADC deficiency.

News

FDA advisors split on Biogen’s ALS therapy

But unanimous vote on biomarker validity could support accelerated approval of tofersen.

News

Novartis pulls plug on landmark UK cholesterol trial

ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.

NICE backs Keytruda for incurable cervical cancer via CDF

23andMe, Novartis team up to put Lp(a) on patients’ radar

Patients rely on Google more than information leaflets

PTC’s gene therapy for rare disease cleared for NHS use

FDA advisors split on Biogen’s ALS therapy

Novartis pulls plug on landmark UK cholesterol trial

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks